AnaptysBio Litigation Post-Trial Briefing Schedule Set

AnaptysBio, Inc. announced the post-trial briefing schedule for its consolidated litigation against Tesaro, Inc. and GlaxoSmithKline. The trial concluded on July 17, 2026, and a Joint Stipulation and Proposed Order for the schedule was granted by the Delaware Court of Chancery on July 28, 2026. The schedule outlines deadlines for opening, answering, and reply briefs, with post-trial arguments set for October 20, 2026.